Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

Journal of Neurosurgery
N F KassellW M Alves

Abstract

Tirilazad mesylate, a nonglucocorticoid 21-aminosteroid, has been shown in experimental models to reduce vasospasm following subarachnoid hemorrhage (SAH) and to reduce infarct size from focal cerebral ischemia. To test whether treatment with tirilazad would reduce ischemic symptoms from vasospasm and improve overall outcome in patients with ruptured aneurysms, a prospective randomized, double-blind, vehicle-controlled trial was conducted at 41 neurosurgical centers in Europe, Australia, and New Zealand. One thousand twenty-three patients were randomly assigned to receive 0.6, 2, or 6 mg/kg per day of intravenously administered tirilazad or a placebo containing the citrate vehicle. All patients were also treated with intravenously administered nimodipine. Patients receiving 6 mg/kg per day of tirilazad had reduced mortality (p = 0.01) and a greater frequency of good recovery on the Glasgow Outcome Scale 3 months after SAH (p = 0.01) than similar patients treated with vehicle. There was a reduction in symptomatic vasospasm in the group that received 6 mg/kg per day tirilazad; however, the difference was not statistically significant (p = 0.048). The benefits of treatment with tirilazad were predominantly shown in men rather than...Continue Reading

References

Mar 1, 1975·Lancet·B Jennett, M Bond
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·D XueA M Buchan
Jul 1, 1990·Stroke; a Journal of Cerebral Circulation·J W Schmidley
Jan 1, 1974·Zhonghua yi xue za zhi
Nov 1, 1994·Stroke; a Journal of Cerebral Circulation·P LydenJ Marler
Aug 1, 1995·American Journal of Therapeutics·Joseph C. FleishakerGary R. Peters

❮ Previous
Next ❯

Citations

Jun 17, 1999·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·W L Lanier
Feb 28, 2006·Neurosurgical Review·R Loch Macdonald
Nov 30, 2000·Current Treatment Options in Neurology·K D FlemmingD O Wiebers
Sep 24, 2008·Neurocritical Care·Yeon Gyoe JangR Loch Macdonald
Feb 9, 2012·Neurocritical Care·Alfredo Conti, Francesco Tomasello
Dec 17, 2010·Molecular Neurobiology·Fatima A SehbaJohn H Zhang
Dec 3, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Khalid A Hanafy, Magdy H Selim
Dec 1, 1995·Journal of the Neurological Sciences·E D Hall
May 12, 2005·Annales Françaises D'anesthèsie Et De Rèanimation·J BerréL Puybasset
Feb 5, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Edward D HallAyman G Mustafa
Sep 3, 1998·European Journal of Pharmacology·T T Rohn, M T Quinn
Sep 21, 2001·Acta Neurochirurgica. Supplement·K AokiJ H Zhang
Jun 12, 2002·Neuroscience Letters·Alexander Y ZubkovJohn H Zhang
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·D KondziolkaL D Lunsford
Dec 4, 2003·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Manuel SchürkämperHans Jakob Steiger
Jul 23, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·N W Dorsch
Sep 1, 2001·Environmental Toxicology and Pharmacology·N A Coleman
Feb 28, 2004·Journal of Neurotrauma·Hülya BayirPatrick M Kochanek
May 22, 2007·Journal of Neurotrauma·Susan L BrattonDavid W Wright
May 15, 2002·Critical Care Medicine·Asita S SarrafzadehAndreas W Unterberg
Jan 21, 2006·Critical Care Medicine·Neeraj S NavalAnish Bhardwaj
Jan 21, 2006·Critical Care Medicine·Thomas P Bleck, Cherylee W J Chang
Oct 24, 1998·Acta Neurologica Scandinavica·N Delanty, M A Dichter
Oct 12, 2010·Stroke; a Journal of Cerebral Circulation·Daniel T Laskowitz, Brad J Kolls
Sep 13, 2011·Annals of Intensive Care·Diego Castanares-Zapatero, Philippe Hantson
Aug 21, 2007·Critical Care : the Official Journal of the Critical Care Forum·Salah G Keyrouz, Michael N Diringer
Apr 13, 2002·Japanese Journal of Pharmacology·Richard SercombePhilippe Gomis
May 31, 2002·Clinical Pharmacokinetics·Bernd MeibohmHartmut Derendorf
May 13, 2003·Clinical Pharmacokinetics·Edzard SchwedhelmRainer H Böger
Mar 26, 2008·Neurologia Medico-chirurgica·Kimiko UmemuraShunro Endo
May 15, 2013·Journal of Neurosurgery·Alan K H TamR Loch Macdonald
Oct 13, 2006·Neurosurgical Focus·George W WeyerR Loch Macdonald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.